Fumitaka Murakami

Dr. Fumitaka Murakami


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
TNTakumi Nagasawa
Takumi Nagasawa
KSKoji Sakamaki
Koji Sakamaki
AYAkihiro Yoshida
Akihiro Yoshida
HMHIROKI MACHIDA
HIROKI MACHIDA
FMFumitaka Murakami
Fumitaka Murakami
TKTakao Kimura
Takao Kimura
Background/Objectives: This study aimed to identify the regulatory system of lipoprotein lipase (LPL), glycosylphosphatidylinositol-anchored high-density lipoprotein (HDL)-binding protein 1 (GPIHBP1), and hepatic triglyceride lipase (HTGL) in the peripheral bloodstream. Methods: In total, 207 individuals (100 males and 107 females) who were diagnosed with normal glucose tolerance or prediabetes during their comprehensive health checkup were investigated. Results: Circulating LPL levels were positively correlated with the GPIHBP1 and HDL-cholesterol (HDL-C) levels, and negatively correlated with body mass index (BMI), waist circumference (WC), Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) scores, triglyceride–glucose index, and triglyceride, fasting insulin, ferritin, and C-reactive protein (CRP) levels. The GPIHBP1 level was positively correlated with LPL and HTGL levels, and negatively correlated with estimated glomerular filtration rate (eGFR). The HTGL level was positively correlated with BMI, WC, HOMA-IR score, and GPIHBP1, low-density lipoprotein cholesterol (LDL-C), fasting insulin, and ferritin levels. Meanwhile, it was negatively correlated with HDL-C levels. The multiple regression analysis revealed that the circulating LPL level was independently affected by BMI, red blood cell (RBC) count, GPIHBP1, fasting plasma glucose (FPG), fasting insulin, HDL-C, CRP, and ferritin levels. The GPIHBP1 level was independently affected by age, eGFR, FPG, LPL, and HTGL levels and RBC count. The HTGL level was independently affected by WC, GPIHBP1 and LDL-C levels. Conclusions: LPL and HTGL levels reflect insulin resistance. In particular, individuals with a greater insulin resistance present with a lower LPL level and a higher HTGL level. An increased GPIHBP1 level might compensate for decreased LPL levels due to insulin resistance.

2 March 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
AYAkihiro Yoshida
Akihiro Yoshida
TNTakumi Nagasawa
Takumi Nagasawa
MIMadoka Inoue
Madoka Inoue
SHSuguru Hiramoto
Suguru Hiramoto
FMFumitaka Murakami
Fumitaka Murakami
TKTakao Kimura
Takao Kimura
Objectives: This study aimed to identify factors influencing the magnitude of the difference between plasma glucose concentration (Glu(P)) and serum glucose concentration (Glu(S)). Methods: A total of 333 healthy Japanese adults aged 22–29 years (212 males and 121 females) were enrolled. Plasma samples were collected using glycolytic inhibitors, whereas serum samples were obtained without glycolytic inhibitors and kept at room temperature. Glu(P) and Glu(S) were measured and compared. Results: The median difference between Glu(P) and Glu(S), defined as Glu(P-S), was 4 mg/dL across all participants, with no gender-related differences. A strong positive correlation was observed between Glu(P) and Glu(S). Glu(P-S) was positively correlated with body mass index, Glu(P), triglyceride–glucose index, white blood cell count, serum sodium, magnesium, and zinc levels. In contrast, Glu(P-S) was negatively correlated with Glu(S), hemoglobin A1c (HbA1c), homeostasis model assessment of beta-cell function, and high-density lipoprotein cholesterol (HDL-C). Multiple regression analysis demonstrated that HDL-C and HbA1c were independent determinants of Glu(P-S) in the overall cohort. Among females, HDL-C, triglyceride, low-density lipoprotein cholesterol, ferritin, and C-reactive protein independently influenced Glu(P-S), whereas no independent determinants were identified in males. Conclusions: Plasma glucose concentrations measured with glycolytic inhibitors were significantly higher than serum glucose concentrations measured without inhibitors at room temperature. The magnitude of Glu(P-S) appears to be associated with markers of insulin resistance, particularly HDL-C levels.